Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up

被引：270

作者：

Bellmunt, J. ^{[1
,2
]}

Orsola, A. ^{[3
]}

Leow, J. J. ^{[1
,2
]}

Wiegel, T. ^{[4
]}

De Santis, M. ^{[5
]}

Horwich, A. ^{[6
,7
]}

机构：

[1] Univ Hosp Mar IMIM, Dept Med Oncol, Barcelona, Spain

[2] Brigham & Womens Hosp, Dana Farber Canc Inst, Bladder Canc Ctr, Boston, MA 02115 USA

[3] Vall Hebron Univ Hosp, Dept Urol, Barcelona, Spain

[4] Univ Hosp Ulm, Dept Radio Oncol, Ulm, Germany

[5] Kaiser Franz Josef Spital, Ludwig Boltzmann Inst Appl Canc Res, Vienna, Austria

[6] Inst Canc Res, Sutton, Surrey, England

[7] Royal Marsden Hosp, Sutton, Surrey, England

来源：

ANNALS OF ONCOLOGY | 2014年 / 25卷

关键词：

TRANSITIONAL-CELL CARCINOMA; EAU INTERNATIONAL CONSULTATION; INVASIVE UROTHELIAL CARCINOMA; SELECTIVE ORGAN PRESERVATION; DOXORUBICIN PLUS GEMCITABINE; COLONY-STIMULATING FACTOR; LONG-TERM-SURVIVAL; PHASE-III TRIAL; PROGNOSTIC-FACTORS; G-CSF;

D O I：

10.1093/annonc/mdu223

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

[No abstract available]

引用

页码：40 / 48

页数：9

共 47 条

[1]

Somatic mutation of fibroblast growth factor receptor-3 (FGFR3) defines a distinct morphological subtype of high-grade urothelial carcinoma [J].

Al-Ahmadie, Hikmat A. ;

Iyer, Gopa ;

Janakiraman, Manickam ;

Lin, Oscar ;

Heguy, Adriana ;

Tickoo, Satish K. ;

Fine, Samson W. ;

Gopalan, Anuradha ;

Chen, Ying-bei ;

Balar, Arjun ;

Riches, Jamie ;

Bochner, Bernard ;

Dalbagni, Guido ;

Bajorin, Dean F. ;

Reuter, Victor E. ;

Milowsky, Matthew I. ;

Solit, David B. .

JOURNAL OF PATHOLOGY, 2011, 224 (02) :270-279

[2]

ICUD-EAU International Consultation on Bladder Cancer 2012: Pathology [J].

Amin, Mahul B. ;

McKenney, Jesse K. ;

Paner, Gladell P. ;

Hansel, Donna E. ;

Grignon, David J. ;

Montironi, Rodolfo ;

Lin, Oscar ;

Jorda, Merce ;

Jenkins, Lawrence C. ;

Soloway, Mark ;

Epstein, Jonathan I. ;

Reuter, Victor E. .

EUROPEAN UROLOGY, 2013, 63 (01) :16-35

[3]

[Anonymous], COCHRANE DATABASE SY

[4]

[Anonymous], 2010, AJCC CANC STAGING MA

[5]

[Anonymous], 2012, Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012

[6]

EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013 [J].

Babjuk, Marko ;

Burger, Maximilian ;

Zigeuner, Richard ;

Shariat, Shahrokh F. ;

van Rhijn, Bas W. G. ;

Comperat, Eva ;

Sylvester, Richard J. ;

Kaasinen, Eero ;

Boehle, Andreas ;

Palou Redorta, Joan ;

Roupret, Morgan .

EUROPEAN UROLOGY, 2013, 64 (04) :639-653

[7]

Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy [J].

Bajorin, DF ;

Dodd, PM ;

Mazumdar, M ;

Fazzari, M ;

McCaffrey, JA ;

Scher, HI ;

Herr, H ;

Higgins, G ;

Boyle, MG .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (10) :3173-3181

[8]

Docetaxel and cisplatin with granulocyte colony-stimulating factor (G-CSF) versus MVAC with G-CSF in advanced urothelial carcinoma: A multicenter, randomized, phase III study from the Hellenic Cooperative Oncology Group [J].

Bamias, A ;

Aravantinos, G ;

Deliveliotis, C ;

Bafaloukos, D ;

Kalofonos, C ;

Xiros, N ;

Zervas, A ;

Mitropoulos, D ;

Samantas, E ;

Pectasides, D ;

Papakostas, P ;

Gika, D ;

Kourousis, C ;

Koutras, A ;

Papadimitriou, C ;

Bamias, C ;

Kosmidis, P ;

Dimopoulos, MA .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (02) :220-228

[9]

Bellmunt J, 2008, ASCO GENITOURINARY C

[10]

Randomized Phase III Study Comparing Paclitaxel/Cisplatin/Gemcitabine and Gemcitabine/Cisplatin in Patients With Locally Advanced or Metastatic Urothelial Cancer Without Prior Systemic Therapy: EORTC Intergroup Study 30987 [J].

Bellmunt, Joaquim ;

von der Maase, Hans ;

Mead, Graham M. ;

Skoneczna, Iwona ;

De Santis, Maria ;

Daugaard, Gedske ;

Boehle, Andreas ;

Chevreau, Christine ;

Paz-Ares, Luis ;

Laufman, Leslie R. ;

Winquist, Eric ;

Raghavan, Derek ;

Marreaud, Sandrine ;

Collette, Sandra ;

Sylvester, Richard ;

de Wit, Ronald .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (10) :1107-1113

← 1 2 3 4 5 →